Ascendis Pharma A/S (ASND) Q2 2026 earnings — TrendMatrix coverage
Reported
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Full disclosure
Key numbers
- Reported EPS
- $0.90
- Estimate
- $0.77
- Surprise
- +17.4%
- Score at report (before → after)
- 6.1 → 6.8/10
Revenue for this quarter isn’t shown: the reported figure hasn’t cleared TrendMatrix’s freshness and sanity checks yet, and consensus revenue isn’t tracked. EPS above is the available figure.
How the report landed
Ascendis Pharma A/S (ASND) beat the $0.77 estimate with diluted EPS of $0.90 — a large 17.4% upside surprise. TrendMatrix's engine moved from Sell (6.1/10) to Hold at 6.8/10 after the report.
Where TrendMatrix's rating stands now
TrendMatrix currently rates ASND Buy (Wait) at 7.0/10.
2 of the last 4 quarters beat the estimate; this quarter's +17.4% surprise compares with a +107.4% four-quarter average.
What supports the rating
- V7 flight-to-quality bonus: +0.5 (Q=8.3 in RISK_OFF)
- Sector modifier (Healthcare): +0.5
What argues against it
- Thin upside margin: 5.2%
- Near 52-week high (4.5% away)
- RISK-OFF: MID-cap BUY_NOW needs quality>=8.5 or MoS>=50%
This section and the ones below it reflect TrendMatrix’s latest engine read — they update after the report date and are not frozen to it.
The levels TrendMatrix's engine tracks
- Current price
- $269.97
- Entry target
- $243.41
- Price target
- $283.47
- Stop
- $227.19
- Upside to target
- +5.0%
- Reward-to-risk
- 0.5:1
Forward estimates sit below the trailing run-rate (28.7× forward vs 20.6× trailing) — consensus expects earnings to decline from here.
Model outputs from TrendMatrix’s engine as of 2026-09-04 — shown for context, not personalized investment advice.
ASND at TrendMatrix's latest read
Healthcare earnings trade on pipeline and payer dynamics as much as the quarter itself; a beat or miss is weighed against trial and reimbursement news.
- Industry
- Biotechnology
- Market cap
- $17.78B
- P/E (fwd)
- 28.7
- P/E (ttm)
- 20.6
- 52-week range
- $186.05–$282.15
- Off 52-week high
- 4.3%
- RSI (14)
- 69
- Volume vs avg
- 0.73×
- Score today
- 7.0/10